DE4233842A1 - Mesna Injektionslösungen - Google Patents

Mesna Injektionslösungen

Info

Publication number
DE4233842A1
DE4233842A1 DE4233842A DE4233842A DE4233842A1 DE 4233842 A1 DE4233842 A1 DE 4233842A1 DE 4233842 A DE4233842 A DE 4233842A DE 4233842 A DE4233842 A DE 4233842A DE 4233842 A1 DE4233842 A1 DE 4233842A1
Authority
DE
Germany
Prior art keywords
mesna
solution
injection
oxygen
bottles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE4233842A
Other languages
German (de)
English (en)
Inventor
Juergen Prof Dr Engel
Elisabeth Dr Wolf-Heuss
Wolfgang Dr Deger
Giancarlo Camuglia
Dieter Sauerbier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asta Medica GmbH
Original Assignee
Asta Medica GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica GmbH filed Critical Asta Medica GmbH
Priority to DE4233842A priority Critical patent/DE4233842A1/de
Priority to TW082106854A priority patent/TW279131B/zh
Priority to ES93114670T priority patent/ES2089661T3/es
Priority to DE59303067T priority patent/DE59303067D1/de
Priority to DK93114670.8T priority patent/DK0591710T3/da
Priority to AT93114670T priority patent/ATE139693T1/de
Priority to EP93114670A priority patent/EP0591710B1/de
Priority to EG64293A priority patent/EG20308A/xx
Priority to IL10718793A priority patent/IL107187A/en
Priority to SI9300525A priority patent/SI9300525A/sl
Priority to CN93118643A priority patent/CN1071114C/zh
Priority to JP25042793A priority patent/JP3636372B2/ja
Priority to NZ248873A priority patent/NZ248873A/en
Priority to UA93002240A priority patent/UA26134C2/uk
Priority to BR9304151A priority patent/BR9304151A/pt
Priority to KR1019930020576A priority patent/KR100364466B1/ko
Priority to RU93048160A priority patent/RU2105550C1/ru
Priority to CZ932097A priority patent/CZ284584B6/cs
Priority to HU9302837A priority patent/HU217123B/hu
Priority to NO933590A priority patent/NO303712B1/no
Priority to ZA937458A priority patent/ZA937458B/xx
Priority to AU48883/93A priority patent/AU667129B2/en
Priority to FI934410A priority patent/FI111804B/fi
Priority to HRP4233842.5A priority patent/HRP931267B1/xx
Priority to SK1079-93A priority patent/SK279609B6/sk
Priority to CA002107961A priority patent/CA2107961C/en
Publication of DE4233842A1 publication Critical patent/DE4233842A1/de
Priority to US08/474,246 priority patent/US5728738A/en
Priority to US08/636,821 priority patent/US5696172A/en
Priority to GR960402027T priority patent/GR3020669T3/el
Priority to HK7397A priority patent/HK7397A/xx
Priority to US08/915,586 priority patent/US5834520A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/105—Persulfides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Filling Or Discharging Of Gas Storage Vessels (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Luminescent Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE4233842A 1992-10-08 1992-10-08 Mesna Injektionslösungen Withdrawn DE4233842A1 (de)

Priority Applications (31)

Application Number Priority Date Filing Date Title
DE4233842A DE4233842A1 (de) 1992-10-08 1992-10-08 Mesna Injektionslösungen
TW082106854A TW279131B (cg-RX-API-DMAC10.html) 1992-10-08 1993-08-24
ES93114670T ES2089661T3 (es) 1992-10-08 1993-09-13 Soluciones para inyeccion de mesna.
DE59303067T DE59303067D1 (de) 1992-10-08 1993-09-13 Mesna-Injektionslösungen
DK93114670.8T DK0591710T3 (da) 1992-10-08 1993-09-13 Injektionsopløsninger indeholdende mesna
AT93114670T ATE139693T1 (de) 1992-10-08 1993-09-13 Mesna-injektionslösungen
EP93114670A EP0591710B1 (de) 1992-10-08 1993-09-13 Mesna-Injektionslösungen
EG64293A EG20308A (en) 1992-10-08 1993-10-03 Process for preparing of injectable solutions
IL10718793A IL107187A (en) 1992-10-08 1993-10-05 Stable injectable mesna solutions
SI9300525A SI9300525A (en) 1992-10-08 1993-10-05 Injection solution containing mesna
CN93118643A CN1071114C (zh) 1992-10-08 1993-10-05 可注射咪斯钠溶液
KR1019930020576A KR100364466B1 (ko) 1992-10-08 1993-10-06 주사용메스나용액,이의제조방법및이를함유하는약제
NZ248873A NZ248873A (en) 1992-10-08 1993-10-06 Sodium-2-mercaptoethane sulphonate in the form of an alkaline injectable solution
UA93002240A UA26134C2 (uk) 1992-10-08 1993-10-06 Спосіб отримаhhя іh'єкційhого розчиhу hатрій-2-меркаптоетаhсульфоhату
BR9304151A BR9304151A (pt) 1992-10-08 1993-10-06 Soluçao de injeçao da mesma, processo para sua produçao, aplicaçao dessa coluçâo e produto farmaceutico para evitar o efeito colateral de oxazafosforina
JP25042793A JP3636372B2 (ja) 1992-10-08 1993-10-06 メスナ注射液、その製造方法およびそれからなる、オキシアザホスホリン副作用をさけるための医薬
FI934410A FI111804B (fi) 1992-10-08 1993-10-07 Menetelmä mesna-injektioliuoksen valmistamiseksi
CA002107961A CA2107961C (en) 1992-10-08 1993-10-07 Injectable mesna solutions
HU9302837A HU217123B (hu) 1992-10-08 1993-10-07 Eljárás javított stabilitású Mesna injekciós oldatok előállítására
NO933590A NO303712B1 (no) 1992-10-08 1993-10-07 Mesna injeksjonsopplasninger samt deres anvendelse
ZA937458A ZA937458B (en) 1992-10-08 1993-10-07 Injectable mesna solutions
AU48883/93A AU667129B2 (en) 1992-10-08 1993-10-07 Injectable mesna solutions
RU93048160A RU2105550C1 (ru) 1992-10-08 1993-10-07 Способ получения инъекционного раствора натрий-2-меркаптоэтансульфоната (месны)
HRP4233842.5A HRP931267B1 (en) 1992-10-08 1993-10-07 Mesna injection solutions
SK1079-93A SK279609B6 (sk) 1992-10-08 1993-10-07 Injekčný roztok mesny, spôsob jeho výroby, liečivo
CZ932097A CZ284584B6 (cs) 1992-10-08 1993-10-07 Injekční roztoky mesny
US08/474,246 US5728738A (en) 1992-10-08 1995-06-07 Injectable mesna solutions
US08/636,821 US5696172A (en) 1992-10-08 1996-04-23 Injectable mesna solutions
GR960402027T GR3020669T3 (en) 1992-10-08 1996-07-31 Injection solutions containing mesna
HK7397A HK7397A (en) 1992-10-08 1997-01-16 Injection solutions containing mesna
US08/915,586 US5834520A (en) 1992-10-08 1997-08-21 Container for injectable mesna solutions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4233842A DE4233842A1 (de) 1992-10-08 1992-10-08 Mesna Injektionslösungen

Publications (1)

Publication Number Publication Date
DE4233842A1 true DE4233842A1 (de) 1994-04-14

Family

ID=6469925

Family Applications (2)

Application Number Title Priority Date Filing Date
DE4233842A Withdrawn DE4233842A1 (de) 1992-10-08 1992-10-08 Mesna Injektionslösungen
DE59303067T Expired - Lifetime DE59303067D1 (de) 1992-10-08 1993-09-13 Mesna-Injektionslösungen

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE59303067T Expired - Lifetime DE59303067D1 (de) 1992-10-08 1993-09-13 Mesna-Injektionslösungen

Country Status (28)

Country Link
US (2) US5728738A (cg-RX-API-DMAC10.html)
EP (1) EP0591710B1 (cg-RX-API-DMAC10.html)
JP (1) JP3636372B2 (cg-RX-API-DMAC10.html)
KR (1) KR100364466B1 (cg-RX-API-DMAC10.html)
CN (1) CN1071114C (cg-RX-API-DMAC10.html)
AT (1) ATE139693T1 (cg-RX-API-DMAC10.html)
AU (1) AU667129B2 (cg-RX-API-DMAC10.html)
BR (1) BR9304151A (cg-RX-API-DMAC10.html)
CA (1) CA2107961C (cg-RX-API-DMAC10.html)
CZ (1) CZ284584B6 (cg-RX-API-DMAC10.html)
DE (2) DE4233842A1 (cg-RX-API-DMAC10.html)
DK (1) DK0591710T3 (cg-RX-API-DMAC10.html)
EG (1) EG20308A (cg-RX-API-DMAC10.html)
ES (1) ES2089661T3 (cg-RX-API-DMAC10.html)
FI (1) FI111804B (cg-RX-API-DMAC10.html)
GR (1) GR3020669T3 (cg-RX-API-DMAC10.html)
HK (1) HK7397A (cg-RX-API-DMAC10.html)
HR (1) HRP931267B1 (cg-RX-API-DMAC10.html)
HU (1) HU217123B (cg-RX-API-DMAC10.html)
IL (1) IL107187A (cg-RX-API-DMAC10.html)
NO (1) NO303712B1 (cg-RX-API-DMAC10.html)
NZ (1) NZ248873A (cg-RX-API-DMAC10.html)
RU (1) RU2105550C1 (cg-RX-API-DMAC10.html)
SI (1) SI9300525A (cg-RX-API-DMAC10.html)
SK (1) SK279609B6 (cg-RX-API-DMAC10.html)
TW (1) TW279131B (cg-RX-API-DMAC10.html)
UA (1) UA26134C2 (cg-RX-API-DMAC10.html)
ZA (1) ZA937458B (cg-RX-API-DMAC10.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
IT1284973B1 (it) * 1996-10-11 1998-05-28 A R D O Associazione Ricerca E Uso del sodio 2-mercaptoetansolfonato (mesna) in chirurgia
US6031006A (en) * 1999-10-21 2000-02-29 Bionumerik Pharmaceuticals, Inc. Method of treating diabetic nephropathy
TW201036529A (en) 2009-03-25 2010-10-01 Askey Computer Corp A liquid crystal anti-freeze method and a liquid crystal module using the liquid crystal anti-freeze method
UA74097U (ru) * 2012-07-24 2012-10-10 Николай Иванович Гуменюк Способ изготовления средства для лечения туберкулеза
PL2994062T3 (pl) * 2013-05-07 2020-05-18 Auxin Surgery Sa Urządzenie do dysekcji wspomaganej chemicznie
US20200289144A1 (en) * 2016-03-14 2020-09-17 Auxin Surgery Sa Device, method and formulation for chemically assisted dissection
BE1024110B1 (fr) * 2016-10-18 2017-11-16 Auxin Surgery Sa Dispositif, procédé et formulation pour dissection assistée de manière chimique

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3111770C2 (cg-RX-API-DMAC10.html) * 1981-03-25 1991-05-08 Heyl Chemisch-Pharmazeutische Fabrik Gmbh & Co Kg, 1000 Berlin, De

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1185551B (it) * 1985-04-15 1987-11-12 Schering Spa Composizioni farmaceutiche a base di acido mercaptoetansolfonico ad attivita' terapeutica,derivati salini organici dell'acido mercaptoetansolfonico utili per tali composizioni e relativo procedimento di preparazione
ES2040394T3 (es) * 1988-03-19 1993-10-16 Asta Medica Aktiengesellschaft Procedimiento para preparar un material liofilizado de ifosfamida y mesna.

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3111770C2 (cg-RX-API-DMAC10.html) * 1981-03-25 1991-05-08 Heyl Chemisch-Pharmazeutische Fabrik Gmbh & Co Kg, 1000 Berlin, De

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Rote Liste 1992, Ed.Cantor, Aulendorf, Präp.Nr.12028, 23161 und 71058 *

Also Published As

Publication number Publication date
JPH06263629A (ja) 1994-09-20
JP3636372B2 (ja) 2005-04-06
DK0591710T3 (da) 1996-09-30
KR940008678A (ko) 1994-05-16
CZ209793A3 (en) 1994-04-13
HUT65096A (en) 1994-04-28
HU9302837D0 (en) 1993-12-28
NO933590D0 (no) 1993-10-07
KR100364466B1 (ko) 2003-01-29
CN1071114C (zh) 2001-09-19
HRP931267B1 (en) 1997-08-31
GR3020669T3 (en) 1996-10-31
NO933590L (no) 1994-04-11
ATE139693T1 (de) 1996-07-15
BR9304151A (pt) 1994-06-07
RU2105550C1 (ru) 1998-02-27
FI934410A0 (fi) 1993-10-07
US5728738A (en) 1998-03-17
CZ284584B6 (cs) 1999-01-13
IL107187A (en) 1999-03-12
EP0591710B1 (de) 1996-06-26
IL107187A0 (en) 1994-01-25
CA2107961A1 (en) 1994-04-09
ZA937458B (en) 1994-04-26
AU4888393A (en) 1994-04-21
CA2107961C (en) 2003-03-25
TW279131B (cg-RX-API-DMAC10.html) 1996-06-21
SI9300525A (en) 1994-06-30
CN1089137A (zh) 1994-07-13
FI111804B (fi) 2003-09-30
EG20308A (en) 1998-10-31
SK107993A3 (en) 1994-05-11
DE59303067D1 (de) 1996-08-01
HRP931267A2 (en) 1994-12-31
HU217123B (hu) 1999-11-29
ES2089661T3 (es) 1996-10-01
HK7397A (en) 1997-01-24
NZ248873A (en) 1995-10-26
EP0591710A1 (de) 1994-04-13
US5696172A (en) 1997-12-09
NO303712B1 (no) 1998-08-24
UA26134C2 (uk) 1999-06-07
SK279609B6 (sk) 1999-01-11
AU667129B2 (en) 1996-03-07
FI934410L (fi) 1994-04-09

Similar Documents

Publication Publication Date Title
DE3240177C2 (cg-RX-API-DMAC10.html)
DE69920201T2 (de) Zusammensetzungen enthaltend glykolderivate, alkohole und vitamin d
EP1206281A1 (de) Moxifloxacin kochsalzformulierung
EP1255557B1 (de) Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung enthaltend desmopressin
WO2001078732A1 (de) Lagerstabile infusionslösung des ciprofloxacins
EP1206244B1 (de) Wässrige arzneimittelformulierung von moxifloxacin oder salzen davon
EP0591710B1 (de) Mesna-Injektionslösungen
DE602005002495T2 (de) Injizierbare Formulierung mit Natriumdiclofenac, Beta-Cyclodextrin und einem Polysorbat
DE68902300T2 (de) Pharmazeutische loesung enthaltend salbutamol und cromoglycinsaeure.
DE2223237C2 (de) Lösung zur pharmazeutischen Verwendung
DE69300017T2 (de) Wässrige pharmazeutische Zubereitung von Natriumcromoglykat.
DE4228552A1 (de) Diphosphonsäuren und deren Salze enthaltende Arzneimittel
DE60113255T2 (de) Neue formulierungen von -g(a)-2,4-disulfophenyl-n-tert-butylnitron
EP2243477A1 (de) Paracetamol zur parenteralen Verabreichung
EP1073469B1 (de) Stabile mitoxantron-lösungen
DE3700379C2 (cg-RX-API-DMAC10.html)
EP1320368A1 (de) Lagerstabile infusionslösung des ciprofloxacins mit verringertem säuregehalt
DE3324964A1 (de) Waessrige pharmazeutische formulierung auf basis eines vincaalkaloids
DE68912947T2 (de) Ein lösliches ibopamin-salz enthaltende augenarzneizubereitung.
US5834520A (en) Container for injectable mesna solutions
DE68905178T2 (de) Stabile waessrige zubereitung von aktivem vitamin-d-3.
EP1282422A1 (de) Infusionslösungen des ciprofloxacins mit verbesserter lagerfähigkeit
DE3907079A1 (de) Ifosfamid-mesna-lyophilisat und verfahren zu dessen herstellung
SI9300029A (en) Lecithin-containing solutions with levemopamil
EP0627222A1 (de) Infusions- und Injektionspräparate enthaltend Dexamethason-21-Phosphat-di-Natrium Salz und Polysorbate

Legal Events

Date Code Title Description
OM8 Search report available as to paragraph 43 lit. 1 sentence 1 patent law
8141 Disposal/no request for examination